Daniel Grint
@danieljgrint
Statistician @LSHTM / @ISEG_LSHTM | TB and HIV treatment clinical trialist | Electronic health records analyst | Running man
ID: 1688537386701950976
07-08-2023 13:07:47
6 Tweet
22 Followers
56 Following
Delighted to finally share the results from this trial of short course high- dose rifampicin regimens for pulmonary TB! London School of Hygiene & Tropical Medicine International Statistics and Epidemiology Group
A higher dose and shorter treatment time of a cornerstone tuberculosis drug has proven to be safe for patients, according to results from the Rifashort trial led by St George’s researchers and published in NEJM Evidence. Find out more: sgul.ac.uk/news/higher-do… City St George's Infect Immunity
